XML 16 R4.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Operating expenses:        
Research and development $ 19,796 $ 16,537 $ 63,931 $ 50,520
General and administrative 3,774 3,579 11,911 11,641
Total operating expenses 23,570 20,116 75,842 62,161
Loss from operations (23,570) (20,116) (75,842) (62,161)
Other income (expense):        
Interest income 766 230 2,534 343
Other income (expense), net 35 (1,338) 1,268 (2,115)
Total other income (expense) 801 (1,108) 3,802 (1,772)
Net loss $ (22,769) $ (21,224) $ (72,040) $ (63,933)
Net loss per share, basic (in dollars per share) $ (0.51) $ (0.69) $ (1.63) $ (2.16)
Net loss per share, diluted (in dollars per share) $ (0.51) $ (0.69) $ (1.63) $ (2.16)
Weighted-average common shares outstanding, basic (in shares) 44,574,377 30,564,995 44,227,264 29,655,946
Weighted-average common shares outstanding, diluted (in shares) 44,574,377 30,564,995 44,227,264 29,655,946